Table of Content

1 Report Overview
1.1 Human Coagulation Factor IX Definition
1.2 Market by Type
1.2.1 Global Human Coagulation Factor IX Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 AHGB
1.2.3 AHFB
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global Human Coagulation Factor IX Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Personal Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Human Coagulation Factor IX Sales
2.1 Global Human Coagulation Factor IX Revenue Estimates and Forecasts 2018-2034
2.2 Global Human Coagulation Factor IX Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Human Coagulation Factor IX Revenue by Region
2.3.1 Global Human Coagulation Factor IX Revenue by Region (2018-2023)
2.3.2 Global Human Coagulation Factor IX Revenue by Region (2024-2034)
2.4 Global Human Coagulation Factor IX Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Human Coagulation Factor IX Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Human Coagulation Factor IX Sales Quantity by Region
2.6.1 Global Human Coagulation Factor IX Sales Quantity by Region (2018-2023)
2.6.2 Global Human Coagulation Factor IX Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Human Coagulation Factor IX Sales Quantity by Manufacturers
3.1.1 Global Human Coagulation Factor IX Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Human Coagulation Factor IX Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor IX Sales in 2024
3.2 Global Human Coagulation Factor IX Revenue by Manufacturers
3.2.1 Global Human Coagulation Factor IX Revenue by Manufacturers (2018-2023)
3.2.2 Global Human Coagulation Factor IX Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor IX Revenue in 2024
3.3 Global Human Coagulation Factor IX Sales Price by Manufacturers
3.4 Global Key Players of Human Coagulation Factor IX, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Coagulation Factor IX, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Coagulation Factor IX, Product Offered and Application
3.8 Global Key Manufacturers of Human Coagulation Factor IX, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Human Coagulation Factor IX Sales Quantity by Type
4.1.1 Global Human Coagulation Factor IX Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Human Coagulation Factor IX Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Human Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
4.2 Global Human Coagulation Factor IX Revenue by Type
4.2.1 Global Human Coagulation Factor IX Historical Revenue by Type (2018-2023)
4.2.2 Global Human Coagulation Factor IX Forecasted Revenue by Type (2024-2034)
4.2.3 Global Human Coagulation Factor IX Revenue Market Share by Type (2018-2034)
4.3 Global Human Coagulation Factor IX Price by Type
4.3.1 Global Human Coagulation Factor IX Price by Type (2018-2023)
4.3.2 Global Human Coagulation Factor IX Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Human Coagulation Factor IX Sales Quantity by Application
5.1.1 Global Human Coagulation Factor IX Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Human Coagulation Factor IX Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Human Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
5.2 Global Human Coagulation Factor IX Revenue by Application
5.2.1 Global Human Coagulation Factor IX Historical Revenue by Application (2018-2023)
5.2.2 Global Human Coagulation Factor IX Forecasted Revenue by Application (2024-2034)
5.2.3 Global Human Coagulation Factor IX Revenue Market Share by Application (2018-2034)
5.3 Global Human Coagulation Factor IX Price by Application
5.3.1 Global Human Coagulation Factor IX Price by Application (2018-2023)
5.3.2 Global Human Coagulation Factor IX Price Forecast by Application (2024-2034)
6 North America
6.1 North America Human Coagulation Factor IX Sales by Company
6.1.1 North America Human Coagulation Factor IX Revenue by Company (2018-2023)
6.1.2 North America Human Coagulation Factor IX Sales Quantity by Company (2018-2023)
6.2 North America Human Coagulation Factor IX Market Size by Type
6.2.1 North America Human Coagulation Factor IX Sales Quantity by Type (2018-2034)
6.2.2 North America Human Coagulation Factor IX Revenue by Type (2018-2034)
6.3 North America Human Coagulation Factor IX Market Size by Application
6.3.1 North America Human Coagulation Factor IX Sales Quantity by Application (2018-2034)
6.3.2 North America Human Coagulation Factor IX Revenue by Application (2018-2034)
6.4 North America Human Coagulation Factor IX Market Size by Country
6.4.1 North America Human Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Human Coagulation Factor IX Revenue by Country (2018-2034)
6.4.3 North America Human Coagulation Factor IX Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Human Coagulation Factor IX Sales by Company
7.1.1 Europe Human Coagulation Factor IX Sales Quantity by Company (2018-2023)
7.1.2 Europe Human Coagulation Factor IX Revenue by Company (2018-2023)
7.2 Europe Human Coagulation Factor IX Market Size by Type
7.2.1 Europe Human Coagulation Factor IX Sales Quantity by Type (2018-2034)
7.2.2 Europe Human Coagulation Factor IX Revenue by Type (2018-2034)
7.3 Europe Human Coagulation Factor IX Market Size by Application
7.3.1 Europe Human Coagulation Factor IX Sales Quantity by Application (2018-2034)
7.3.2 Europe Human Coagulation Factor IX Revenue by Application (2018-2034)
7.4 Europe Human Coagulation Factor IX Market Size by Country
7.4.1 Europe Human Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Human Coagulation Factor IX Revenue by Country (2018-2034)
7.4.3 Europe Human Coagulation Factor IX Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Human Coagulation Factor IX Sales by Company
8.1.1 China Human Coagulation Factor IX Sales Quantity by Company (2018-2023)
8.1.2 China Human Coagulation Factor IX Revenue by Company (2018-2023)
8.2 China Human Coagulation Factor IX Market Size by Type
8.2.1 China Human Coagulation Factor IX Sales Quantity by Type (2018-2034)
8.2.2 China Human Coagulation Factor IX Revenue by Type (2018-2034)
8.3 China Human Coagulation Factor IX Market Size by Application
8.3.1 China Human Coagulation Factor IX Sales Quantity by Application (2018-2034)
8.3.2 China Human Coagulation Factor IX Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Human Coagulation Factor IX Sales by Company
9.1.1 APAC Human Coagulation Factor IX Sales Quantity by Company (2018-2023)
9.1.2 APAC Human Coagulation Factor IX Revenue by Company (2018-2023)
9.2 APAC Human Coagulation Factor IX Market Size by Type
9.2.1 APAC Human Coagulation Factor IX Sales Quantity by Type (2018-2034)
9.2.2 APAC Human Coagulation Factor IX Revenue by Type (2018-2034)
9.3 APAC Human Coagulation Factor IX Market Size by Application
9.3.1 APAC Human Coagulation Factor IX Sales Quantity by Application (2018-2034)
9.3.2 APAC Human Coagulation Factor IX Revenue by Application (2018-2034)
9.4 APAC Human Coagulation Factor IX Market Size by Region
9.4.1 APAC Human Coagulation Factor IX Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Human Coagulation Factor IX Revenue by Region (2018-2034)
9.4.3 APAC Human Coagulation Factor IX Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Coagulation Factor IX Sales by Company
10.1.1 Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Human Coagulation Factor IX Market Size by Type
10.2.1 Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Human Coagulation Factor IX Market Size by Application
10.3.1 Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Human Coagulation Factor IX Market Size by Country
10.4.1 Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Grifols
11.1.1 Grifols Company Information
11.1.2 Grifols Overview
11.1.3 Grifols Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Grifols Human Coagulation Factor IX Products and Services
11.1.5 Grifols Human Coagulation Factor IX SWOT Analysis
11.1.6 Grifols Recent Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Overview
11.2.3 Biogen Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Biogen Human Coagulation Factor IX Products and Services
11.2.5 Biogen Human Coagulation Factor IX SWOT Analysis
11.2.6 Biogen Recent Developments
11.3 Octapharma
11.3.1 Octapharma Company Information
11.3.2 Octapharma Overview
11.3.3 Octapharma Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Octapharma Human Coagulation Factor IX Products and Services
11.3.5 Octapharma Human Coagulation Factor IX SWOT Analysis
11.3.6 Octapharma Recent Developments
11.4 Baxter
11.4.1 Baxter Company Information
11.4.2 Baxter Overview
11.4.3 Baxter Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Baxter Human Coagulation Factor IX Products and Services
11.4.5 Baxter Human Coagulation Factor IX SWOT Analysis
11.4.6 Baxter Recent Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Overview
11.5.3 Bayer Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Bayer Human Coagulation Factor IX Products and Services
11.5.5 Bayer Human Coagulation Factor IX SWOT Analysis
11.5.6 Bayer Recent Developments
11.6 CSL
11.6.1 CSL Company Information
11.6.2 CSL Overview
11.6.3 CSL Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 CSL Human Coagulation Factor IX Products and Services
11.6.5 CSL Human Coagulation Factor IX SWOT Analysis
11.6.6 CSL Recent Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Overview
11.7.3 Novo Nordisk Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Novo Nordisk Human Coagulation Factor IX Products and Services
11.7.5 Novo Nordisk Human Coagulation Factor IX SWOT Analysis
11.7.6 Novo Nordisk Recent Developments
11.8 Greencross
11.8.1 Greencross Company Information
11.8.2 Greencross Overview
11.8.3 Greencross Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Greencross Human Coagulation Factor IX Products and Services
11.8.5 Greencross Human Coagulation Factor IX SWOT Analysis
11.8.6 Greencross Recent Developments
11.9 Kedrion
11.9.1 Kedrion Company Information
11.9.2 Kedrion Overview
11.9.3 Kedrion Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Kedrion Human Coagulation Factor IX Products and Services
11.9.5 Kedrion Human Coagulation Factor IX SWOT Analysis
11.9.6 Kedrion Recent Developments
11.10 BPL
11.10.1 BPL Company Information
11.10.2 BPL Overview
11.10.3 BPL Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 BPL Human Coagulation Factor IX Products and Services
11.10.5 BPL Human Coagulation Factor IX SWOT Analysis
11.10.6 BPL Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Company Information
11.11.2 Hualan Bio Overview
11.11.3 Hualan Bio Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Hualan Bio Human Coagulation Factor IX Products and Services
11.11.5 Hualan Bio Recent Developments
11.12 RAAS
11.12.1 RAAS Company Information
11.12.2 RAAS Overview
11.12.3 RAAS Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 RAAS Human Coagulation Factor IX Products and Services
11.12.5 RAAS Recent Developments
11.13 Pfizer
11.13.1 Pfizer Company Information
11.13.2 Pfizer Overview
11.13.3 Pfizer Human Coagulation Factor IX Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Pfizer Human Coagulation Factor IX Products and Services
11.13.5 Pfizer Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Coagulation Factor IX Value Chain Analysis
12.2 Human Coagulation Factor IX Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Coagulation Factor IX Production Mode & Process
12.4 Human Coagulation Factor IX Sales and Marketing
12.4.1 Human Coagulation Factor IX Sales Channels
12.4.2 Human Coagulation Factor IX Distributors
12.5 Human Coagulation Factor IX Customers
13 Market Dynamics
13.1 Human Coagulation Factor IX Industry Trends
13.2 Human Coagulation Factor IX Market Drivers
13.3 Human Coagulation Factor IX Market Challenges
13.4 Human Coagulation Factor IX Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of AHGB
Table 3. Major Manufacturers of AHFB
Table 4. Major Manufacturers of Others
Table 5. Global Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Human Coagulation Factor IX Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Human Coagulation Factor IX Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Human Coagulation Factor IX Revenue Market Share by Region (2018-2023)
Table 9. Global Human Coagulation Factor IX Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Human Coagulation Factor IX Revenue Market Share by Region (2024-2034)
Table 11. Global Human Coagulation Factor IX Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 12. Global Human Coagulation Factor IX Sales by Region (2018-2023) & (K Pcs)
Table 13. Global Human Coagulation Factor IX Sales Market Share by Region (2018-2023)
Table 14. Global Human Coagulation Factor IX Sales by Region (2024-2034) & (K Pcs)
Table 15. Global Human Coagulation Factor IX Sales Market Share by Region (2024-2034)
Table 16. Global Human Coagulation Factor IX Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 17. Global Human Coagulation Factor IX Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Human Coagulation Factor IX Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Human Coagulation Factor IX Revenue Share by Manufacturers (2018-2023)
Table 20. Global Human Coagulation Factor IX Price by Manufacturers 2018-2023 (USD/Pcs)
Table 21. Global Key Players of Human Coagulation Factor IX, Industry Ranking, 2021 VS 2024
Table 22. Global Human Coagulation Factor IX Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Human Coagulation Factor IX by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Coagulation Factor IX as of 2024)
Table 24. Global Key Manufacturers of Human Coagulation Factor IX, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Human Coagulation Factor IX, Product Offered and Application
Table 26. Global Key Manufacturers of Human Coagulation Factor IX, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Human Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Pcs)
Table 29. Global Human Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Pcs)
Table 30. Global Human Coagulation Factor IX Sales Quantity Share by Type (2018-2023)
Table 31. Global Human Coagulation Factor IX Sales Quantity Share by Type (2024-2034)
Table 32. Global Human Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Human Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Human Coagulation Factor IX Revenue Share by Type (2018-2023)
Table 35. Global Human Coagulation Factor IX Revenue Share by Type (2024-2034)
Table 36. Human Coagulation Factor IX Price by Type (2018-2023) & (USD/Pcs)
Table 37. Global Human Coagulation Factor IX Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 38. Global Human Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Pcs)
Table 39. Global Human Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Pcs)
Table 40. Global Human Coagulation Factor IX Sales Quantity Share by Application (2018-2023)
Table 41. Global Human Coagulation Factor IX Sales Quantity Share by Application (2024-2034)
Table 42. Global Human Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Human Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Human Coagulation Factor IX Revenue Share by Application (2018-2023)
Table 45. Global Human Coagulation Factor IX Revenue Share by Application (2024-2034)
Table 46. Human Coagulation Factor IX Price by Application (2018-2023) & (USD/Pcs)
Table 47. Global Human Coagulation Factor IX Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 48. North America Human Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Human Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Pcs)
Table 50. North America Human Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Pcs)
Table 51. North America Human Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Pcs)
Table 52. North America Human Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Human Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Human Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Pcs)
Table 55. North America Human Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Pcs)
Table 56. North America Human Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Human Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Human Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Human Coagulation Factor IX Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Human Coagulation Factor IX Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Human Coagulation Factor IX Sales Quantity by Country (2018-2023) & (K Pcs)
Table 62. North America Human Coagulation Factor IX Sales Quantity by Country (2024-2034) & (K Pcs)
Table 63. Europe Human Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Pcs)
Table 64. Europe Human Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Human Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Pcs)
Table 66. Europe Human Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Pcs)
Table 67. Europe Human Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Human Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Human Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Pcs)
Table 70. Europe Human Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Pcs)
Table 71. Europe Human Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Human Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Human Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Human Coagulation Factor IX Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Human Coagulation Factor IX Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Human Coagulation Factor IX Sales Quantity by Country (2018-2023) & (K Pcs)
Table 77. Europe Human Coagulation Factor IX Sales Quantity by Country (2024-2034) & (K Pcs)
Table 78. China Human Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Pcs)
Table 79. China Human Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Human Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Pcs)
Table 81. China Human Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Pcs)
Table 82. China Human Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Human Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Human Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Pcs)
Table 85. China Human Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Pcs)
Table 86. China Human Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Human Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Human Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Pcs)
Table 89. APAC Human Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Human Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Pcs)
Table 91. APAC Human Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Pcs)
Table 92. APAC Human Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Human Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Human Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Pcs)
Table 95. APAC Human Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Pcs)
Table 96. APAC Human Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Human Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Human Coagulation Factor IX Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Human Coagulation Factor IX Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Human Coagulation Factor IX Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Human Coagulation Factor IX Sales Quantity by Region (2018-2023) & (K Pcs)
Table 102. APAC Human Coagulation Factor IX Sales Quantity by Region (2024-2034) & (K Pcs)
Table 103. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Company (2018-2023) & (K Pcs)
Table 104. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Type (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Type (2024-2034) & (K Pcs)
Table 107. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Application (2018-2023) & (K Pcs)
Table 110. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Application (2024-2034) & (K Pcs)
Table 111. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Country (2018-2023) & (K Pcs)
Table 117. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity by Country (2024-2034) & (K Pcs)
Table 118. Grifols Company Information
Table 119. Grifols Description and Overview
Table 120. Grifols Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 121. Grifols Human Coagulation Factor IX Product and Services
Table 122. Grifols Human Coagulation Factor IX SWOT Analysis
Table 123. Grifols Recent Developments
Table 124. Biogen Company Information
Table 125. Biogen Description and Overview
Table 126. Biogen Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 127. Biogen Human Coagulation Factor IX Product and Services
Table 128. Biogen Human Coagulation Factor IX SWOT Analysis
Table 129. Biogen Recent Developments
Table 130. Octapharma Company Information
Table 131. Octapharma Description and Overview
Table 132. Octapharma Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 133. Octapharma Human Coagulation Factor IX Product and Services
Table 134. Octapharma Human Coagulation Factor IX SWOT Analysis
Table 135. Octapharma Recent Developments
Table 136. Baxter Company Information
Table 137. Baxter Description and Overview
Table 138. Baxter Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 139. Baxter Human Coagulation Factor IX Product and Services
Table 140. Baxter Human Coagulation Factor IX SWOT Analysis
Table 141. Baxter Recent Developments
Table 142. Bayer Company Information
Table 143. Bayer Description and Overview
Table 144. Bayer Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 145. Bayer Human Coagulation Factor IX Product and Services
Table 146. Bayer Human Coagulation Factor IX SWOT Analysis
Table 147. Bayer Recent Developments
Table 148. CSL Company Information
Table 149. CSL Description and Overview
Table 150. CSL Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 151. CSL Human Coagulation Factor IX Product and Services
Table 152. CSL Human Coagulation Factor IX SWOT Analysis
Table 153. CSL Recent Developments
Table 154. Novo Nordisk Company Information
Table 155. Novo Nordisk Description and Overview
Table 156. Novo Nordisk Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 157. Novo Nordisk Human Coagulation Factor IX Product and Services
Table 158. Novo Nordisk Human Coagulation Factor IX SWOT Analysis
Table 159. Novo Nordisk Recent Developments
Table 160. Greencross Company Information
Table 161. Greencross Description and Overview
Table 162. Greencross Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 163. Greencross Human Coagulation Factor IX Product and Services
Table 164. Greencross Human Coagulation Factor IX SWOT Analysis
Table 165. Greencross Recent Developments
Table 166. Kedrion Company Information
Table 167. Kedrion Description and Overview
Table 168. Kedrion Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 169. Kedrion Human Coagulation Factor IX Product and Services
Table 170. Kedrion Human Coagulation Factor IX SWOT Analysis
Table 171. Kedrion Recent Developments
Table 172. BPL Company Information
Table 173. BPL Description and Overview
Table 174. BPL Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 175. BPL Human Coagulation Factor IX Product and Services
Table 176. BPL Human Coagulation Factor IX SWOT Analysis
Table 177. BPL Recent Developments
Table 178. Hualan Bio Company Information
Table 179. Hualan Bio Description and Overview
Table 180. Hualan Bio Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 181. Hualan Bio Human Coagulation Factor IX Product and Services
Table 182. Hualan Bio Recent Developments
Table 183. RAAS Company Information
Table 184. RAAS Description and Overview
Table 185. RAAS Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 186. RAAS Human Coagulation Factor IX Product and Services
Table 187. RAAS Recent Developments
Table 188. Pfizer Company Information
Table 189. Pfizer Description and Overview
Table 190. Pfizer Human Coagulation Factor IX Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 191. Pfizer Human Coagulation Factor IX Product and Services
Table 192. Pfizer Recent Developments
Table 193. Key Raw Materials Lists
Table 194. Raw Materials Key Suppliers Lists
Table 195. Human Coagulation Factor IX Distributors List
Table 196. Human Coagulation Factor IX Customers List
Table 197. Human Coagulation Factor IX Market Trends
Table 198. Human Coagulation Factor IX Market Drivers
Table 199. Human Coagulation Factor IX Market Challenges
Table 200. Human Coagulation Factor IX Market Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor IX Product Picture
Figure 2. Global Human Coagulation Factor IX Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Human Coagulation Factor IX Market Share by Type in 2024 & 2034
Figure 4. AHGB Product Picture
Figure 5. AHFB Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human Coagulation Factor IX Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Human Coagulation Factor IX Market Share by Application in 2024 & 2034
Figure 9. Hospital
Figure 10. Personal Clinic
Figure 11. Others
Figure 12. Human Coagulation Factor IX Report Years Considered
Figure 13. Global Human Coagulation Factor IX Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Human Coagulation Factor IX Revenue 2018-2034 (US$ Million)
Figure 15. Global Human Coagulation Factor IX Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Human Coagulation Factor IX Sales Quantity 2018-2034 (K Pcs)
Figure 17. Global Human Coagulation Factor IX Sales Quantity Market Share by Region (2018-2023)
Figure 18. Global Human Coagulation Factor IX Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Human Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 20. North America Human Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Human Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. Europe Human Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Human Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. China Human Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Human Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. APAC Human Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Human Coagulation Factor IX Sales Quantity in 2024
Figure 30. The Top 10 and Top 5 Players Market Share by Human Coagulation Factor IX Revenue in 2024
Figure 31. Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Human Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Human Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 34. Global Human Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Human Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 36. North America Human Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 37. North America Human Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 38. North America Human Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Human Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 40. North America Human Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Human Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 42. North America Human Coagulation Factor IX Revenue Share by Country (2018-2034)
Figure 43. North America Human Coagulation Factor IX Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Human Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 47. Europe Human Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 48. Europe Human Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Human Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 50. Europe Human Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Human Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 52. Europe Human Coagulation Factor IX Revenue Share by Country (2018-2034)
Figure 53. Europe Human Coagulation Factor IX Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 55. France Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 59. China Human Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 60. China Human Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 61. China Human Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Human Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 63. China Human Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Human Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 65. APAC Human Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 66. APAC Human Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 67. APAC Human Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Human Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 69. APAC Human Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Human Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 71. APAC Human Coagulation Factor IX Revenue Share by Region (2018-2034)
Figure 72. APAC Human Coagulation Factor IX Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 77. India Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity Market Share by Company in 2024
Figure 79. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue Market Share by Company in 2024
Figure 80. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Human Coagulation Factor IX Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Human Coagulation Factor IX Revenue Share by Country (2018-2034)
Figure 86. Brazil Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Human Coagulation Factor IX Revenue (2018-2034) & (US$ Million)
Figure 91. Human Coagulation Factor IX Value Chain
Figure 92. Human Coagulation Factor IX Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed